Analysis of the original antigenic sin antibody response to the major outer membrane protein of Chlamydia trachomatis

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 180-186

  Berry, Jody D ^a   Peeling, Rosanna W ^a   Brunham, Robert C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; EPITOPE; OUTER MEMBRANE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENIC VARIATION; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDIA TRACHOMATIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SEROTYPING;

EID: 0032930032     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314538     Document Type: Article

References (32)

1. Wang S, Grayston JT. Local and systemic antibody response to trachoma eye infection in monkeys. In: Trachoma and related disorders caused by chlamydial agents. London: Excerpta Medica, 1970:217-32.
2. Wang S, Grayston JT. Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis 1974;130:388-97.
3. Wang S, Grayston JT Microimunofluorescence antibody responses in Chlamydia trachomatis infection, a review. In: Mardh PA, Holmes KK, Oriel JD, Piot P, Schacter J, eds. Chlamydial infections. New York: Elsevier Biomedical, 1982:301-16.
4. Wang SP, Grayston JT. Micro-immunofluorescence serology of Chlamydia trachomatis. In: de la Maza L, Peterson E, eds. Medical virology. 3rd ed. New York: Elsevier Science, 1984:87-118.
5. Davenport FM, Hennesy AV, Francis T. Epidemiological and immunological significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 1953;98:641-7.
6. Fazekas de St Groth S, Webster RG. Disquisitions on original antigenic sin. I. Evidence in man. J Exp Med 1966;124:331-45.
7. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996;272:54-60.
8. Kalinke U, Bucher EM, Ernst B, et al. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. Immunity 1996;5:639-52.
9. Sieskevitz M, Kocks C, Rajewsky K, Dildrop R. Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses. Cell 1987;48:757-70.
10. Fish S, Fleming M, Sharon J, Manser T. Different epitope structures select distinct forms of an antibody variable region for expression during the immune response. J Exp Med 1991;173:665-72.
11. Brown AR, DeWitt C, Bosma M, Nisonoff A. Dominance of an immune response by secondary cells: quantitation by allotype analysis. J Immunol 1980;124:250-4.
12. Janeway CA, Travers P. Immunobiology. 3rd ed. Vol 9. New York: Garland, 1997:47.
13. Eisen HN, Little JR, Steiner LA, Simms ES, Gray W. Degeneracy in the secondary immune response: stimulation of antibody formation by cross-reacting antigens. Israel J Med Sci 1969;5:338-51.
14. Fish S, Zenowich E, Fleming M, Manser T. Molecular analysis of original antigenic sin. I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response. J Exp Med 1989;170:1191-209.
15. East IJ, Todd PEE, Leach SJ. Original antigenic sin: experiments with a defined antigen. Mol Immunol 1980;17:1539-44.
16. Zhao Q, Lammel C, Lindquist E, Stephens RS. Recall of original serologic response after challenge with homologous and heterologous Chlamydia trachomatis serovars. J Infect Dis 1996;173:609-18.
17. Fan J, Stephens RS. Antigen conformation dependence of Chlamydia trachomatis infectivity neutralization. J Infect Dis 1997;176:713-21.
18. Nara PL. Humoral immunity to HIV-1: lethal force or Trojan horse? In: Gupta S, ed. Immunology of HIV infection. Chapter 12. New York: Plenum, 1996:243-69.
19. Zhong G, Berry J, Brunham RC. Antibody recognition of a neutralization epitope on the major outer membrane protein on Chlamydia trachomatis. Infect Immun 1994;62:1576-83.
20. Yuan Y, Zhang Y, Watkins N, Caldwell HD. Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun 1989;57:1040-9.
21. Geysen MN, Rodda J, Mason JT, Tribbick G, Schoofs GP. Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987;102:259-74.
22. Zhong G, Brunham RC. Antigenic determinants of the chlamydial major outer membrane protein resolved at a single amino acid level. Infect Immun 1991;59:1141-7.
23. Grayston JT, Kim KS, Alexander ER, Wang SP. Protective studies in monkeys with trivalent and monovalent trachoma vaccines. In: Trachoma and related disorders caused by chlamydial agents. New York: Excerpta Medica, 1970:377-85.
24. Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis 1996;173:950-6.
25. Mabey D, Bailey R. Immunity to Chlamydia trachomatis: lessons from a Gambian village. J Med Microbiol 1996;45:1-2.
26. Marsh K, Howard RJ. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 1986;231:150-3.
27. Schachter J. Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev Infect Dis 1985;7:713-6.
28. Schwartzkoff CL, Egerton J, Stewart D, Lehrbach P, Elleman T, Hoyne PA. The effects of antigenic competition on the efficacy of multivalent footrot vaccines. Aust Vet J 1993;70:123-6.
29. Ada G, Ramsay A. Vaccines, vaccination, and the immune response. Philadelphia: Lippincott-Raven, 1996.
30. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis 1990;161:667-79.
31. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997;337:1181-7.
32. Klinman DM, Higgins KW, Conover J. Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells. J Exp Med 1991;173:881-7.